Secretion of chemokines and other cytokines in allergen-induced nasal responses: Inhibition by topical steroid treatment

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 3, 1995, Pages 927-933

  Sim, Tommy C ^a   Reece, Lisa M ^a   Hilsmeier, Kimberly A ^a   Grant, J Andrew ^a   Alam, Rafeul ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; CHEMOKINE; CYTOKINE; DECONGESTIVE AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HOUSE DUST ALLERGEN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NOSE SPRAY; OXYMETAZOLINE; RANTES; STEROID;

AEROSOL; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; NOSE ALLERGY; NOSE MUCOSA; NOSE SECRETION; PRIORITY JOURNAL; PROVOCATION TEST; RAGWEED POLLEN; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0029145018     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.152.3.7545059     Document Type: Article

References (37)

1. Borish, L. 1991. Cytokines and allergy. In E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., and J. W. Yunginger, editors. Allergy Principles and Practice, 3rd ed., update no. 9. C. V. Mosby Co., St. Louis.
2. Bochner, B. S., E. N. Charlesworth, L. M. Lichtenstein, C. P. Derse, S. Gillis, C. A. Dinarello, and R. P. Schleimer. 1990. Interleukin-1 is released at sites of human cutaneous allergic reactions. J. Allergy Clin. Immunol. 86:830-839.
3. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
4. Lee, C. E., M. E. Neuland, H. G. Teaford, B. F. Villacis, P. S. Dixon, S. Valtier, C. H. Yeh, D. C. Fournier, and E. N. Charlesworth. 1992. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J. Allergy Clin. Immunol. 89:1010-1020.
5. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97-179.
6. Baggiolini, M., and C. A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today 15:127-132.
7. Alam, R., M. A. Lett-Brown, P. A. Forsythe, D. J. Anderson-Walters, C. Kenamore, C. Kormos, and J. A. Grant. 1992. Monocyte chemotactic and activating factor (MCAF) is a potent histamine-releasing factor for basophils. J. Clin. Invest. 89:723-728.
8. Alam, R., P. A. Forsythe, S. Stafford, M. A. Lett-Brown, and J. A. Grant. 1992. Macrophage inflammatory protein-1α activates basophils and mast cells. J. Exp. Med. 176:781-786.
9. Dahinden, C. A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 79:751-756.
10. Alam, R., P. A. Forsythe, S. Stafford, J. Heinrich, R. Bravo, P. Proost, and J. Van Damme. 1994. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J. Immunol. 153:3155-3159.
11. Alam, R., T. C. Sim, K. A. Hilsmeier, and J. A. Grant. 1992. Development of a new technique for recovery of cytokines from inflammatory sites in situ. J. Immunol. Methods 155:25-29.
12. Sim, T. C., J. A. Grant, K. A. Hilsmeier, and R. Alam. 1994. Detection of proinflammatory cytokines in the nasal secretions of allergic subjects following allergen challenge. Am. J. Respir. Crit. Care Med. 149:339-344.
13. Siegel, S. C. 1988. Topical intranasal corticosteroid therapy in rhinitis. J. Allergy Clin. Immunol. 81:984-991.
14. Bascom, R., M. Wachs, R. M. Naclerio, D. Proud, A. Kagey-Sobotka, P. S. Norman, and L. M. Lichtenstein. 1988. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J. Allergy Clin. Immunol. 81:580-589.
15. Pipkorn, U., D. Proud, L. M. Lichtenstein, A. Kagey-Sobotka, P. S. Norman, and R. M. Naclerio. 1987. Inhibition of mediator release in allergic rhinitis by pretreatment with topical corticosteroids. N. Engl. J. Med. 316:1506-1510.
16. Sim, T. C., K. A. Hilsmeier, R. Alam, R. K. Allen, M. A. Lett-Brown, and J. A. Grant. 1992. Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis. Am. Rev. Respir. Dis. 145:1316-1320.
17. Naclerio, R. M., H. L. Meier, A. Kagey-Sobotka, D. Proud, P. S. Norman, and L. M. Lichtenstein. 1983. Mediator release after nasal airway challenge with allergen. Am. Rev. Respir. Dis. 128:597-602.
18. Dinarello, C. A. 1989. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:153-205.
19. Bochner, B. S., F. W. Luskinskas, M. A. J. Gimbrone, Jr., W. Newman, S. A. Sterbinsky, C. P. Derse-Anthony, D. Klunk, and R. P. Schleimer. 1991. Adhesion of human basophils, eosinophils and neutrophils to IL-1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J. Exp. Med. 173: 1553-1556.
20. Silberstein, D. S., W. F. Owen, J. C. Gasson, J. F. DiPersio, D. W. Golde, J. C. Bina, R. Soberman, K. F. Austen, and J. R. David. 1986. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol. 137:3290-3295.
21. Lamas, A. M., G. V. Marcotte, and R. P. Schleimer. 1989. Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids. J. Immunol. 142:3978-3984.
22. Dahinden, C. A., Y. Kurimoto, A. L. De Week, I. Lindley, B. Dewald, and M. Baggiolini. 1989. The neutrophil activating peptide NAF/ NAP-1 causes histamine and leukotriene release by interleukin-3-primed basophils. J. Exp. Med. 170:1787-1792.
23. Sehmi, R., O. Cromwell, A. J. Wardlaw, R. Moqbel, and A. B. Kay. 1993. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin. Exp. Allergy 23:1027-1036.
24. Kuna, P., S. R. Reddigari, T. J. Schall, D. Rucinski, M. Sadick, and A. P. Kaplan. 1993. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J. Immunol. 150:1932-1943.
25. Alam, R., S. Stafford, P. A. Forsythe, R. Harrison, D. Faubion, M. A. Lett-Brown, and J. A. Grant. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150:3442-3447.
26. Bacon, K. B., L. Flores-Romo, J. P. Aubry, T. N. C. Wells, and C. A. Power. 1994. Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers. Immunology 82:473-481.
27. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines. Effect of the chemokine RANTES. J. Immunol. 153:2153-2160.
28. Alam, R., D. Kumar, D. Anderson-Walters, and P. A. Forsythe. 1994. Macrophage inflammatory protein-1α and monocyte chemoattractant protein-1 elicit immediate and late cutaneous reactions and activate mast cells in vivo. J. Immunol. 152:1298-1303.
29. Meurer, R., G. Van Riper, W. Feeney, P. Cunningham, D. Hora, M. S. Springer, D. E. Maclntyre, and H. Rosen. 1993. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8. J. Exp. Med. 178:1913-1921.
30. Alam, R., J. York, M. Boyars, J. A. Grant, S. Stafford, J. Lee, and A. Weido. 1994. The involvement of chemokines in bronchial asthma. The detection of the mRNA for MCP-1, MCP-3, RANTES, MIP-1α, and IL-8 in bronchoalveolar lavage cells and the measurement of RANTES and MIP-1α in the lavage fluid (abstract). Am. J. Respir. Crit. Care Med. 149:A951.
31. Beck, L. A., T. J. Schall, L. D. Beall, D. Leopold, C. Bickel, F. Baroody, R. M. Naclerio, and R. P. Schleimer. 1994. Detection of the chemokine RANTES and activation of vascular endothelium in nasal polyps (abstract). J. Allergy Clin. Immunol. 93:A234.
32. Chrousos, G. P. 1993. Mechanisms of action. In D. T. Boumpas, moderator. Glucocorticoid therapy for immune mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119:1198-1200.
33. Barnes, P. J., and S. Pedersen. 1993. Efficacy and safety of inhaled corticosteroids in asthma. Am. Rev. Respir. Dis. 148:S1-S26.
34. Guyre, P. M., M. T. Girard, P. M. Morganelli, and P. D. Manginiello. 1988. Glucocorticoid effects on the production and action of immune cytokines. J. Steroid Biochem. 30:89-93.
35. Borish, L., J. J. Mascali, J. Dishuck, W. R. Beam, R. J. Martin, and L. J. Rosenwasser. 1992. Detection of alveolar macrophage-derived IL-1β in asthma. Inhibition with corticosteroids. J. Immunol. 149: 3078-3082.
36. Davis, R. J., J. H. Wang, C. G. Trigg, J. L. Devalia, and S. Jordan. 1994. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of mild asthmatics (abstract). Am. J. Respir. Crit. Care Med. 149:A1069.
37. Robinson, D., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. R. Durham, and A. B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.